期刊文献+

CYP4F2基因单体型与心肌梗死的相关性研究 被引量:5

Association on the haplotypes of CYP4F2 gene and myocardial infarction
原文传递
导出
摘要 目的研究CYP4F2基因单体型与心肌梗死的关系。方法250例心肌梗死患者和250例对照分别分为整体组、男性组、女性组。选择CYP4F2基因的5个SNPs(rs3093105、rs3093135、rs1558139、rs2108622、rs3093200),应用TaqManSNP基因分型方法进行基因分型,并应用病例对照单体型分析方法进行相关性研究。结果对于男性,心肌梗死患者rs2108622的G等位基因频率远远高于对照(P=0.005);心肌梗死患者和对照相比较,单体型的总体分布在男性组显著不同(P=0.002);男性组心肌梗死患者的T-C-G单体型频率显著高于对照(P=0.002),男性组心肌梗死患者的T-C—A单体型频率显著低于对照(P=0.003)。结论CYP4F2基因rs2108622的G等位基因可能与男性心肌梗死相关,T-C-G单体型可能是男性心肌梗死的遗传标记。 Objective The aim of this study was to assess the association between human CYP4F2 gene and myocardial infarction (MI),using a haplotype-based case-control study. A separate analysis on gender was also carried out. Methods There were 250 MI patients and 250 control subjects genotyped for 5 SNPs of the human CYP4F2 gene (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200). Data were assessed on 3 separate groups: the total subjects, men and women. Results For men, G allele was significantly higher in the MI patients than in the control subjects and the overall distribution of the haplotypes was significantly different between the MI patients and the control subjects (P=0.002). Also in men, the frequency of T-C-G haplotype was significantly higher for MI patients than for control subjects (P=0.002), and the frequency of T-C-A haplotype was significantly lower for MI patients than for control subjects (P=0.003). Conclusion Data from the present results indicated that MI was associated with G allele of rs2108622 in men, suggesting that T-C-G haplotype might serve as genetic marker for MI in men.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2009年第7期733-736,共4页 Chinese Journal of Epidemiology
基金 新疆维吾尔自治区重大科技专项课题(200733146)
关键词 心肌梗死 CYP4F2 单体型 病例对照 Myocardial infarction CYP4F2 Haplotype Case-control study
  • 相关文献

参考文献19

  • 1Wang XL,Greco M,Sim AS,et al.Effect of CYPIAI Msp I polymorphism on cigarette smoking related coronary artery disease and diabetes.Atherosclerosis,2002,162:391-397.
  • 2Cornelis MC,EI-Sohemy A,Campos H.Genetic polymorphism of CYPIA2 increases the risk of myocardial infarction.J Med Genet,2004,41:758-762.
  • 3Yasar U,Bennet AM,Eliasson E,et al.Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.Pharmacogenetics,2003,13:715-720.
  • 4Funk M,Endler G,Freitag R,et al.CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction.Clin Chem,2004,50:2395-2398.
  • 5Spiecker M,Darius H,Hankeln T,et al.Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.Circulation,2004,110:2132-2136.
  • 6Nakayama T,Soma M,Saito S,et al.Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction.Am Heart J,2002,143:797-801.
  • 7Hengstenberg C,Holmer SR,Mayer B,et al.Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction.Hypertension,2000,35:704-709.
  • 8Letonja M,Peterlin B,Bregar D,et al.Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA)polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians? Folia Biol(Praha),2005,51:76-81.
  • 9Lasker JM,Chen WB,Wolf I,et al.Formation of 20-hydroxyeicosatetraenoic acid,a vasoactive and natriuretic eicosanoid,in human kidney.Role of CYP4F2 and CYP4A11.J Biol Chem,2000,275:4118-4126.
  • 10Stec DE,Roman RJ,Flasch A,et al.Functional polymorphism in human CYP4F2 decreases 20-HETE production.Physiol Genomics,2007,30:74-81.

同被引文献104

  • 1李刚,周兴文.新的冠心病危险因素[J].心血管病学进展,2005,26(3):266-271. 被引量:24
  • 2BORGIANI P,CICCACCI C,FORTE V,et al.CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population[J].Pharmacogenomics,2009,10(2):261-266.
  • 3DENG S,ZHU G,LIU F,et al.CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male Northern Chinese Han population[J].Prog Neuropsychopharmacol Biol Psychiatry,2010,34(4):664-668.
  • 4SCONCE E A,KHAN T I,WYNNE H A,et al.The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements:proposal for a new dosing regimen[J].Blood,2005,106(7):2329-2333.
  • 5WADELIUS M,CHEN L Y,ERIKSSON N,et al.Association of warfarin dose with genes involved in its action and metabolism[J].Hum Genet,2007,121(1):23-34.
  • 6PEREZ ANDREU V,ROLDAN V,ANTON A I,et al.Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy[J].Blood,2009,113(20):4977-4979.
  • 7SINGH O,SANDANARAJ E,SUBRAMANIAN K,et al.Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients[J].Drug Metab Pharmacokinet,2011,26(2):130-136.
  • 8FAVA C,MONTAGNANA M,ALMGREN P,et al.The V433M variant of the CYP4F2 is associated with ischemic stroke in male swedes beyond its effect on blood pressure[J].Hypertension,2008,52 (2):373-380.
  • 9MCDONALD M G,RIEDER M J,NAKANO M,et al.CYP4F2 is a vitamin K1 oxidase:An explanation for altered warfarin dose in carriers of the V433M variant[J].Mol Pharmacol,2009,75(6):1337-1346.
  • 10苏州大学,苏州旷远生物分子技术有限公司.一种用于华法林个体化用药相关基因SNP位点检测的试剂盒及其PCR扩增方法.中国,201010234597.8[P] 2010-12-01.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部